Category: Prescription Drugs
Prescription Drugs market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Anticoagulant Drugs
The 2025-2030 World Outlook for Anticoagulant Drugs This study covers the world outlook for anticoagulant drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Anticoagulant Reversal Drugs
The 2025-2030 World Outlook for Anticoagulant Reversal Drugs This study covers the world outlook for anticoagulant reversal drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Skin Disease Treatment Technologies
The 2025-2030 World Outlook for Skin Disease Treatment Technologies This study covers the world outlook for skin disease treatment technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Companion Animal Drugs
The 2025-2030 World Outlook for Companion Animal Drugs This study covers the world outlook for companion animal drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Gastric Cancer Drugs
The 2025-2030 World Outlook for Gastric Cancer Drugs This study covers the world outlook for gastric cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Ulcerative Proctitis
The 2025-2030 World Outlook for Ulcerative Proctitis This study covers the world outlook for ulcerative proctitis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Thyroid Gland Disorders
The 2025-2030 World Outlook for Thyroid Gland Disorders This study covers the world outlook for thyroid gland disorders across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Anti-Inflammatory Scleroderma Drugs
The 2025-2030 World Outlook for Anti-Inflammatory Scleroderma Drugs This study covers the world outlook for anti-inflammatory scleroderma drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Anti-Migraine Drugs
The 2025-2030 World Outlook for Anti-Migraine Drugs This study covers the world outlook for anti-migraine drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Antifibrinolytic Drugs
The 2025-2030 World Outlook for Antifibrinolytic Drugs This study covers the world outlook for antifibrinolytic drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Acute Agitation and Aggression Treatments
The 2025-2030 World Outlook for Acute Agitation and Aggression Treatments This study covers the world outlook for acute agitation and aggression treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More
-
The 2025-2030 World Outlook for Bipolar Disorder Drugs
The 2025-2030 World Outlook for Bipolar Disorder Drugs This study covers the world outlook for bipolar disorder drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Hunter Syndrome Treatments
The 2025-2030 World Outlook for Hunter Syndrome Treatments This study covers the world outlook for Hunter syndrome treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Fondaparinux
The 2025-2030 World Outlook for Fondaparinux This study covers the world outlook for fondaparinux across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the ... Read More
-
The 2025-2030 World Outlook for Synthetic Statins
The 2025-2030 World Outlook for Synthetic Statins This study covers the world outlook for synthetic statins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Analgesic Osteoarthritis Treatments
The 2025-2030 World Outlook for Analgesic Osteoarthritis Treatments This study covers the world outlook for analgesic osteoarthritis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Alzheimer's Disease Treatments
The 2025-2030 World Outlook for Alzheimer's Disease Treatments This study covers the world outlook for Alzheimer's disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Sedation in ICU Setting
The 2025-2030 World Outlook for Sedation in ICU Setting This study covers the world outlook for sedation in ICU setting across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Synthetic Opioids
The 2025-2030 World Outlook for Synthetic Opioids This study covers the world outlook for synthetic opioids across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Schizophrenia
The 2025-2030 World Outlook for Schizophrenia This study covers the world outlook for schizophrenia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), t ... Read More
-
The 2025-2030 World Outlook for Sarcopenia Treatments
The 2025-2030 World Outlook for Sarcopenia Treatments This study covers the world outlook for sarcopenia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The World Market for Opium Alkaloids, Their Derivatives, and Salts Thereof: A 2024 Global Trade Perspective
The World Market for Opium Alkaloids, Their Derivatives, and Salts Thereof: A 2024 Global Trade Perspective This report was created for strategic planners, international executives, and import/export managers who are concerned with the market for opium alkaloids, their derivatives, and salts thereof ... Read More